Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CRISPR-based m6A modification and its potential applications in telomerase regulation. | Front Cell Dev Biol | 2023 | 37519297 | PubTator, text mining | PubMed |
| m6A methyltransferase KIAA1429 accelerates oral squamous cell carcinoma via regulating glycolysis and ferroptosis. | Transl Oncol | 2023 | 37517144 | PubTator, text mining | PubMed |
| A Ferroptosis-Related lncRNAs Signature Predicts Prognosis of Colon Adenocarcinoma. | Life (Basel) | 2023 | 37511932 | PubTator, text mining | PubMed |
| Infection Meets Inflammation: N6-Methyladenosine, an Internal Messenger RNA Modification as a Tool for Pharmacological Regulation of Host-Pathogen Interactions. | Biomolecules | 2023 | 37509095 | PubTator, text mining | PubMed |
| N6-Methyladenosine Directly Regulates CD40L Expression in CD4+ T Lymphocytes. | Biology (Basel) | 2023 | 37508433 | PubTator, text mining | PubMed |
| Comprehensive analysis of m6A regulators associated with immune infiltration in Hepatitis B virus-related hepatocellular carcinoma. | BMC Gastroenterol | 2023 | 37507670 | PubTator, text mining | PubMed |
| Characterization of epitranscriptome reader proteins experimentally and in silico: Current knowledge and future perspectives beyond the YTH domain. | Comput Struct Biotechnol J | 2023 | 37501707 | PubTator, text mining | PubMed |
| E2F3 induces DNA damage repair, stem-like properties and therapy resistance in breast cancer. | Biochim Biophys Acta Mol Basis Dis | 2023 | 37499929 | PubTator, text mining | PubMed |
| E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies. | Front Immunol | 2023 | 37497216 | PubTator, text mining | PubMed |
| Effects of DNA, RNA, and Protein Methylation on the Regulation of Ferroptosis. | Int J Biol Sci | 2023 | 37497000 | PubTator, text mining | PubMed |
| Significance of methylation-related genes in diagnosis and subtype classification of renal interstitial fibrosis. | Hereditas | 2023 | 37496082 | PubTator, text mining | PubMed |
| FTO-mediated m6A modification alleviates autoimmune uveitis by regulating microglia phenotypes via the GPC4/TLR4/NF-κB signaling axis. | Genes Dis | 2023 | 37492748 | PubTator, text mining | PubMed |
| Profiling the m6A-regulated RNA expression patterns and alternative splicing features in esophageal carcinoma. | Genes Dis | 2023 | 37492731 | PubTator, text mining | PubMed |
| Multilevel regulation of N6-methyladenosine RNA modifications: Implications in tumorigenesis and therapeutic opportunities. | Genes Dis | 2023 | 37492716 | PubTator, text mining | PubMed |
| m6A levels and expression of its modification genes show significant differences in breast cancer molecular subtypes. | Genes Dis | 2023 | 37492710 | PubTator, text mining | PubMed |
| SETD2 controls m6A modification of transcriptome and regulates the molecular oncogenesis of glioma. | Med Oncol | 2023 | 37490181 | PubTator, text mining | PubMed |
| The yeast RNA methylation complex consists of conserved yet reconfigured components with m6A-dependent and independent roles. | Elife | 2023 | 37490041 | PubTator, text mining | PubMed |
| Recognition of the Subtypes Classification and Diagnostic Signature Based on RNA N6-Methyladenosine Regulators in Recurrent Spontaneous Abortion. | Reprod Sci | 2023 | 37488406 | PubTator, text mining | PubMed |
| Novel insight into RNA modifications in tumor immunity: Promising targets to prevent tumor immune escape. | Innovation (Camb) | 2023 | 37485079 | PubTator, text mining | PubMed |
| N6-methyladenosine RNA modification: an emerging molecule in type 2 diabetes metabolism. | Front Endocrinol (Lausanne) | 2023 | 37484964 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=50